Showing results (151-160 of 176) with videos related to

Sort By:
Pageof 18
Circulation|February 8, 2021
Empagliflozin Effects on Pulmonary Artery Pressure in Patients With Heart Failure: Results From the EMBRACE-HF TrialMichael E Nassif, Mohammed Qintar, Sheryl L Windsor, et al.
Arthritis and Rheumatism|July 31, 2013
Phase I, randomized, double-blind, placebo-controlled, multiple intravenous, dose-ascending study of sirukumab in cutaneous or systemic lupus erythematosusJacek C Szepietowski, Surasak Nilganuwong, Anna Wozniacka, et al.
The Journal of Urology|September 18, 2007
Prostate cancer risk assessment program: a 10-year update of cancer detectionVeda N Giri, Jennifer Beebe-Dimmer, Mark Buyyounouski, et al.
Physical Review Letters|March 4, 2014
Novel high-pressure monoclinic metallic phase of V2O3Yang Ding, Cheng-Chien Chen, Qiaoshi Zeng, et al.
Bioorganic & Medicinal Chemistry Letters|March 20, 2003
3,4-Diaryl-5-hydroxyfuranones: highly selective inhibitors of cyclooxygenase-2 with aqueous solubilityW Cameron Black, Christine Brideau, Chi Chung Chan, et al.
Applied Clinical Informatics|December 29, 2021
Continuous Remote Patient Monitoring: Evaluation of the Heart Failure Cascade Soft LaunchWei Ning Chi, Courtney Reamer, Robert Gordon, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|May 18, 2005
Three-year results of a randomized, double-blind, controlled trial of mycophenolate mofetil versus azathioprine in cardiac transplant recipientsHoward J Eisen, Jon Kobashigawa, Anne Keogh, et al.
Bioorganic & Medicinal Chemistry Letters|March 12, 2004
The development of potent non-peptidic PTP-1B inhibitorsClaude Dufresne, Patrick Roy, Zhaoyin Wang, et al.
Transplantation|March 8, 2016
Long-term Follow-up of Kidney Transplant Recipients in the Spare-the-Nephron-TrialMatthew R Weir, Thomas C Pearson, Anita Patel, et al.
Alzheimer'S Research & Therapy|April 18, 2021
A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer's disease with lecanemab, an anti-Aβ protofibril antibodyChad J Swanson, Yong Zhang, Shobha Dhadda, et al.
Pageof 18